Table 1 Summary Statistics of the Lung Cancer Patients.
Characteristics | Total n (% of 21,919) | # of plt counts median (25th–75th percentile) | 5-Year OS n (% of Total Column) | Mean Platelet Count (±SD) | p-value (from mean platelet count) |
|---|---|---|---|---|---|
Overall | 21,919 (100%) | 17 (13–23) | 6,693 (31%) | 242 ± 86 | |
Age(years) | |||||
<60 | 2,819 (13%) | 18 (14–24) | 1,018 (36%) | 259 ± 75 | P < 0.0001 |
≥60 | 19,100 (87%) | 17 (13–23) | 5,675 (30%) | 240 ± 72 | |
Gender | |||||
Female | 526 (2%) | 17 (13–22) | 208 (40%) | 272 ± 80 | P < 0.0001 |
Male | 21,393 (98%) | 17 (13–23) | 6,485 (30%) | 241 ± 72 | |
Cancer stage | |||||
I/II | 9,458 (43%) | 17 (13–23) | 4,632 (49%) | 236 ± 70 | P < 0.0001 |
III/IV | 12,461 (57%) | 17 (13–23) | 2,061 (17%) | 247 ± 73 | |
Race | |||||
Black | 3,652 (17%) | 18 (14–24) | 1,197 (33%) | 249 ± 75 | P < 0.0001 |
White | 17,875 (82%) | 17 (13–23) | 5,370 (30%) | 241 ± 71 | |
Asian | 76 (0.03%) | 16 (13–22) | 28 (37%) | 252 ± 72 | |
Other | 316 (1.4%) | 17 (12–23) | 98 (31%) | 247 ± 84 | |
Smoking | |||||
Never | 545 (2.5%) | 18 (13–24) | 215 (40%) | 227 ± 60 | P < 0.0001 |
Previously | 8,451 (39%) | 17 (13–23) | 2,560 (30%) | 236 ± 70 | |
Current | 10,041 (46%) | 17 (13–23) | 2,996 (30%) | 247 ± 74 | |
Unknown | 2,882 (13%) | 18 (14–23) | 922 (32%) | 242 ± 76 | |
Treatment* | |||||
Surgery | 6,332 (29%) | 16 (12–22) | 3,580 (57%) | 240 ± 69 | P = 0.02 |
Chemotherapy | 11,399 (52%) | 18 (14–23) | 2,584 (23%) | 244 ± 70 | |
Radiation | 9,742 (44%) | 18 (14–24) | 2,466 (25%) | 242 ± 72 | |
Immunotherapy | 188 (0.08%) | 18 (14–25) | 81 (43%) | 243 ± 76 | |
Unknown | 1,995 (9%) | 17 (13–24) | 366 (18%) | 242 ± 76 | |
